Sensei Biotherapeutics Inc.
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 19 institutions reported holding Sensei Biotherapeutics Inc. in their 13F filings, down 5 from Q2 2024. 1 opened new positions and 5 sold out. The largest holders were Ikarian Capital, LLC ($389K), Vanguard Group Inc. ($370K) and Renaissance Technologies ($129K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sensei Biotherapeutics Inc.
- CUSIP
- 81728A108
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $54K |
| Exits | 5 | $23K |
All 13F filers, Q2 2024 → Q3 2024: 182,800 shares bought and 76,029 shares sold, net +106,771 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Ikarian Capital, LLC | 0.12% | No change | 650,000 | $389K |
| Vanguard Group Inc. | 0.00% | No change | 618,757 | $370K |
| Renaissance Technologies | 0.00% | Reduce -3.7% | 215,572 | $129K |
| Boothbay Fund Management, LLC | 0.00% | No change | 172,835 | $103K |
| Geode Capital Management, LLC | 0.00% | No change | 163,139 | $98K |
| Susquehanna International Group, LLP | 0.00% | New | 90,428 | $54K |
| Citadel Advisors | 0.00% | Add +329.8% | 66,044 | $39K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -38.5% | 47,900 | $29K |
| National Bank of Canada | 0.00% | Add +355.8% | 45,575 | $27K |
| Northern Trust Corp. | 0.00% | No change | 25,983 | $16K |
| State Street Corp. | 0.00% | No change | 25,774 | $15K |
| Raymond James & Associates | 0.00% | Add +42.9% | 20,000 | $12K |
| Cresset Asset Management, LLC | 0.00% | No change | 19,671 | $12K |
| XTX Topco Ltd | 0.00% | Reduce -0.9% | 13,926 | $8K |
| Morgan Stanley | 0.00% | No change | 12,219 | $7K |
| Deuterium Capital Management, LLC | 0.01% | No change | 11,000 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.8% | 7,029 | $4K |
| JPMorgan Chase & Co. | 0.00% | Reduce -5.5% | 707 | $422 |
| Bank of America Corp. | 0.00% | Add +85.6% | 258 | $154 |
"% of holder's portfolio" is SENSEI BIOTHERAPEUTICS INC's weight in each manager's 13F, not the share of Sensei Biotherapeutics Inc. the manager owns.